{"id":"W2977259025","doi":"10.1200/jco.2012.30.15_suppl.551","title":"Safety of everolimus for women over 65 years of age with advanced breast cancer (BC): 12.5-mo follow-up of BOLERO-2.","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Everolimus; Exemestane; Internal medicine; Adverse effect; Tolerability; Rash; Breast cancer; Population; Aromatase inhibitor; Placebo; Oncology; Cancer; Aromatase","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001829138,0.0001801012,0.002374892,0.0001341232,0.00001633652,0.000001172287,0.0002091803,0.0002860726,0.0002410572],"category_scores_gemma":[0.000653986,0.0001319738,0.0004824672,0.0001601686,0.0004979084,0.0002378754,0.00004779355,0.0004955321,9.249495e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003122788,"about_ca_system_score_gemma":0.001098655,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004604544,"about_ca_topic_score_gemma":0.00006217899,"domain_scores_codex":[0.9963714,0.00015775,0.002405071,0.0001672285,0.0004763425,0.0004222287],"domain_scores_gemma":[0.9936169,0.001548673,0.0035201,0.000252894,0.0006825692,0.0003788974],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.1542391,0.002504641,0.2214976,0.0004093818,0.002253227,0.0000419545,0.001672649,0.0002814148,0.007470098,0.0001903782,0.0003643976,0.6090752],"study_design_scores_gemma":[0.03737057,0.01138534,0.8977505,0.0005459036,0.0004683592,0.0001893323,0.000496292,0.000009099514,0.000813546,0.0003227173,0.05050394,0.0001443948],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.995716,0.0009296508,0.000726629,0.0007279826,0.001030472,0.000375402,0.0001006769,0.000006193748,0.0003869931],"genre_scores_gemma":[0.9901344,0.0006483031,0.007353878,0.0005437561,0.000845151,0.00001826731,0.000001940206,0.0000402729,0.0004140407],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.676253,"threshold_uncertainty_score":0.5381736,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05455642955437769,"score_gpt":0.4282402993348184,"score_spread":0.3736838697804407,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}